Interactive case: ICANS grading and management

ESH eLearning, Peter Schellongowski, 348357

Interactive case: CRS grading and management

ESH eLearning, Ulrich Jäger, 348356

Panel discussion

ESH eLearning, Faculty / Presenters, 348355

Perspectives: Ongoing clinical trials and developments in DLBCL

ESH eLearning, Gilles SALLES, 348354

Short Oral Presentation: Longitudinal CAR T-Cell Detection and Quantification by Ddpcr in Cellular and Cell-Free DNA in Patients Treated with Tisagenlecleucel

ESH eLearning, Adrian Minson, 348353

Interactive case: Monitoring CAR expansion and persistence?

ESH eLearning, Peter Borchmann, 348352

Case-based lecture: Real world data: patient selection and bridging strategies?

ESH eLearning, Catherine Thieblemont, 348351

Panel Discussion

ESH eLearning, Faculty / Presenters, 348430

Ph-like ALL Patient Management

ESH eLearning, Sarah Tasian, 348429

Next generation TKIs for Ph+ ALL

ESH eLearning, Nicholas Short, 348428

Which TKI-Chemo-Transplant Cocktail for Ph+ ALL?

ESH eLearning, Yves Chalandon, 348427

Panel Discussion

ESH eLearning, Faculty / Presenters, 348426

Novel Therapies for T-ALL/LL

ESH eLearning, Anjali Advani, 348425

Should T-LL and T-ALLs be treated on the same protocols?

ESH eLearning, Elisabeth Macintyre, 348424

Risk Factors in T-ALL

ESH eLearning, Elizabeth Raetz, 348423

Keynote: Management of T-LL Patients

ESH eLearning, Dieter Hoelzer, 348422

Panel Discussion

ESH eLearning, Faculty / Presenters, 348421

Frontline Chemo-free Regimens in Ph+ ALL

ESH eLearning, Sabina Chiaretti, 348420

Panel Discussion

ESH eLearning, Faculty / Presenters, 348419

Post-transplant Interventions

ESH eLearning, David Marks, 348418

New CARs for B-cell Precursor ALL

ESH eLearning, Claire Roddie, 348417

Panel Discussion

ESH eLearning, Faculty / Presenters, 348416

Selected brief oral communication: Oncogenic Cooperation between the TCF7-SPI1 fusion and NRAS(G12D) Requires β-Catenin Activity to Drive T-Cell Acute Lymphoblastic Leukemia

ESH eLearning, Quentin Van, 348415

Selected brief oral communication: Pharmacologic Inhibition of DYRK1A Results in Hyperphosphorylation of ERK and Consequently in Apoptosis of KMT2A-Rearranged ALL

ESH eLearning, Christian Hurtz, 348414

New ALL Drugs

ESH eLearning, Matthew J. Wieduwilt, 348413

TKI Use in Ph+/Ph-like Diseases

ESH eLearning, Stephen P. Hunger, 348412

The Critical Role of Microenvironment in ALL

ESH eLearning, Adele K. Fielding, 348411

Panel Discussion

ESH eLearning, Faculty / Presenters, 348410

Selected brief oral communication: T(1;19)(q23;p13) TCF3-PBX1 May Not be an Intermediate-Risk Subtype in Adult B-Cell Precursor Acute Lymphoblastic Leukemia Patients Treated with MRD-Oriented Protocols from the Pethema Group

ESH eLearning, Jordi Ribera, 348409

Management of Relapsed ALL

ESH eLearning, Elias Jabbour, 348408

Treatment Issues in Teenagers and Young Adults ALL

ESH eLearning, Rachael Hough, 348407

Panel Discussion

ESH eLearning, Faculty / Presenters, 348406

IG-TCR versus BCR-ABL1 MRD in Ph+ ALL

ESH eLearning, Jan Zuna, 348405

Panel Discussion

ESH eLearning, Faculty / Presenters, 348404

Targeting CD3 in T-ALL

ESH eLearning, Jacques Ghysdael, 348403

Aberrant Signaling in T-cell ALL

ESH eLearning, Jan Cools, 348402

Molecular Mechanisms of T-ALL

ESH eLearning, Adolfo Ferrando, 348401

Panel Discussion

ESH eLearning, Faculty / Presenters, 348400

Selected brief oral communication: Mechanistic Basis for Targeting BCL6 in RAS-Driven B-Cell Acute Lymphoblastic Leukemia

ESH eLearning, Lai Chan, 348399

Targeting Novel B-cell progenitor ALL Subtypes

ESH eLearning, Charles Mullighan, 348398

Myeloid Switch of B-cell Precursor ALL Subtypes

ESH eLearning, Ester Mejstrikova, 348397

Transcriptional Landscape of B-cell Precursor ALL

ESH eLearning, Henrik Lilljebjörn, 348396

Keynote: HOX Gene Deregulation in ALL

ESH eLearning, Scott Armstrong, 348395

Discussion

ESH eLearning, Faculty / Presenters, 336538

The future is now, science fiction thereafter

ESH eLearning, Francesca Gay, 336537

There is no future without past

ESH eLearning, Kenneth C. Anderson, 336536

Case-based lecture: How to treat bone disease in multiple myeloma

ESH eLearning, Elena Zamagni, 336533

Brief Oral Communication - Reductions in Absolute Iflc and Dflc Are Associated with Prolonged Major Organ Deterioration Progression-Free Survival in Patients with Newly Diagnosed AL Amyloidosis Receiving Vcd with or without Daratumumab: Results from Andromeda

ESH eLearning, Faculty / Presenters, 336534

Case-based lecture: How I treat MGRS and MGUS with neuropathy

ESH eLearning, Stefan Knop, 336532

Case-based lecture: How I treat amyloidosis

ESH eLearning, GIAMPAOLO MERLINI, 336531

Panel discussion

ESH eLearning, Faculty / Presenters, 336535

Panel discussion

ESH eLearning, Faculty / Presenters, 336530

Brief Oral Communication - Teclistamab, a B-Cell Maturation Antigen (BCMA) X CD3 Bispecific Antibody, in Relapsed and/or Refractory Multiple Myeloma (RRMM): Updated Phase 1 Results

ESH eLearning, Faculty / Presenters, 336529

Brief Oral Communication - Cartitude-1, a Phase 1b/2 Study of Ciltacabtagene Autoleucel in Relapsed/Refractory Multiple Myeloma (RRMM)

ESH eLearning, Deepu Madduri, 336528

Case-based lecture : Future immunotherapies in multiple myeloma

ESH eLearning, Eric Smith, 336527

Case-based lecture : Antibody based immunotherapy

ESH eLearning, Niels W.C.J. van de Donk, 336526

Case-based lecture : CART in multiple myeloma

ESH eLearning, Nina Shah, 336525

Interactive case: Bi- and trispecific antibodies in multiple myeloma

ESH eLearning, Hermann Einsele, 336524

Access to drugs in Europe

ESH eLearning, Jean-Luc Harousseau, 336523

Multiple Myeloma Research Foundation

ESH eLearning, Daniel Auclair, 336522

Food and Drug Administration

ESH eLearning, Bindu Kanapuru, 336521

Discussion

ESH eLearning, Faculty / Presenters, 336520

NO

ESH eLearning, Fredrik Schjesvold, 336519

YES

ESH eLearning, Philippe Moreau, 336518

Brief Oral Communication - HORIZON (OP-106): Melflufen Plus Dexamethasone in 55 Patients with Relapsed/Refractory Multiple Myeloma (RRMM) with Extramedullary Disease (EMD)—Subgroup Analysis

ESH eLearning, PAUL RICHARDSON, 336517

Brief Oral Communication -Talquetamab, a G Protein-Coupled Receptor Family C Group 5 Member D (GPRC5D) X CD3 Bispecific Antibody, in Patients with Relapsed and/or Refractory Multiple Myeloma (RRMM): Results from an Ongoing Phase 1 Study

ESH eLearning, Faculty / Presenters, 336516

Case-based lecture : Novel agents in relapsed multiple myeloma

ESH eLearning, Enrique Ocio, 336515

Case-based lecture : How I treat later relapses

ESH eLearning, Stefan Knop, 336514

Case-based lecture : How I treat first relapse

ESH eLearning, Paula Rodríguez-Otero, 336513

Interactive case: Relapsed multiple myeloma

ESH eLearning, Xavier Leleu, 336512

Discussion

ESH eLearning, Faculty / Presenters, 336511

NO

ESH eLearning, Ola Landgren, 336510

YES

ESH eLearning, Salomon Manier, 336509

Discussion

ESH eLearning, Faculty / Presenters, 336508

NO

ESH eLearning, Angela Dispenzieri, 336507

YES

ESH eLearning, Nikhil Munshi, 336506

Panel discussion

ESH eLearning, Faculty / Presenters, 336505

Case-based lecture : NGS guided targeted and immune therapies in multiple myeloma

ESH eLearning, SAMIR PAREKH, 336503

Case-based lecture : My DRUG - precision interception in multiple myeloma

ESH eLearning, Daniel Auclair, 336504

Interactive case: How I treat a high risk patient

ESH eLearning, Faith Davies, 336502

ESH eLearning, Faculty / Presenters, 336501

Case-based lecture : Tandem transplant in the Dara-era?

ESH eLearning, Charlotte Pawlyn, 336497

Case-based lecture: Are all frail patients frail?

ESH eLearning, Sonja Zweegman, 336498

Brief Oral Communication - Daratumumab Plus Lenalidomide, Bortezomib, and Dexamethasone in Patients with Transplant-Eligible Newly Diagnosed Multiple Myeloma: Updated Analysis of Griffin after 12 Months of Maintenance Therapy

ESH eLearning, Faculty / Presenters, 336499

Panel discussion

ESH eLearning, Faculty / Presenters, 336500

Interactive case: Newly diagnosed transplant eligible multiple myeloma

ESH eLearning, KARTHIK Ramasamy, 336496

Interactive case: Smoldering myeloma

ESH eLearning, María-Victoria Mateos, 336490

Panel discussion

ESH eLearning, Faculty / Presenters, 336495

Brief Oral Communication: Early Diagnosis of Multiple Myeloma By Means of a Computer-Aided Algorithm.

ESH eLearning, Faculty / Presenters, 336494

Case-based lecture: Imaging with PET-CT in SMM

ESH eLearning, Cristina Nanni, 336493

Case-based lecture: Understanding the immune ME of SMM

ESH eLearning, Madhav Dhodapkar, 336492

Case-based lecture: Understanding genomics of SMM

ESH eLearning, Irene Ghobrial, 336491

Panel Discussion

ESH eLearning, Faculty / Presenters, 348350

Inclusion of a shRNA Targeting BCL11A into a β-Globin Expressing Vector Allows Concurrent Synthesis of Curative Adult and Fetal Hemoglobin

ESH eLearning, Danuta Jarocha, 348349

New approcahes for managing SCD

ESH eLearning, Lucia De Franceschi, 348348

New approaches to anemia of MDS

ESH eLearning, Uwe Platzbecker, 348347

Iron restrictided erythropoiesis

ESH eLearning, Tomas Ganz, 348346

Panel Discussion

ESH eLearning, Faculty / Presenters, 348345

Focus on: Immunotherapy and CAR-T in MDS: Dream or reality ?

ESH eLearning, Rafael Bejar, 348344

Gene therapy in hemoglobinophaties vs gene editing

ESH eLearning, Mitchell J. Weiss, 348343